IRIS
GABANO, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.544
NA - Nord America 3.173
AS - Asia 1.164
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 5
Totale 7.902
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.114
IE - Irlanda 1.082
DE - Germania 618
SE - Svezia 528
UA - Ucraina 412
HK - Hong Kong 411
SG - Singapore 340
IT - Italia 298
RU - Federazione Russa 251
FI - Finlandia 249
CN - Cina 248
IN - India 100
CA - Canada 58
GB - Regno Unito 36
IR - Iran 36
BE - Belgio 22
ID - Indonesia 11
TR - Turchia 11
FR - Francia 10
AT - Austria 9
EU - Europa 8
RO - Romania 8
LT - Lituania 5
NL - Olanda 5
VN - Vietnam 5
AL - Albania 4
EG - Egitto 4
BR - Brasile 3
ZA - Sudafrica 3
HR - Croazia 2
PL - Polonia 2
UY - Uruguay 2
ES - Italia 1
HU - Ungheria 1
JO - Giordania 1
MA - Marocco 1
MY - Malesia 1
PA - Panama 1
PT - Portogallo 1
Totale 7.902
Salva come PNG Salva come JPEG
Città #
Dublin 1.075
Jacksonville 746
Dearborn 412
Hong Kong 410
Chandler 217
Wilmington 186
Singapore 173
Ann Arbor 146
Lawrence 134
Princeton 134
Beijing 105
Piemonte 104
Moscow 99
San Mateo 90
Andover 84
Ashburn 60
Bremen 50
Grafing 49
Toronto 49
Munich 43
Novara 29
Helsinki 26
Los Angeles 23
New York 22
Leawood 21
Brussels 20
Cave Creek 19
Hefei 19
Monmouth Junction 18
Woodbridge 18
Zanjan 18
Nanjing 17
Santa Clara 16
Boardman 15
Kunming 15
Norwalk 15
Kocaeli 11
Guangzhou 10
Nuremberg 10
Ardabil 9
Fairfield 9
Jinan 9
Augusta 8
Hebei 8
London 8
Houston 7
Jakarta 7
Udine 7
Wuhan 7
Mülheim 6
Sacramento 6
Shenyang 6
Turin 6
Vienna 6
Winnipeg 6
Como 5
Frankfurt am Main 5
Fuzhou 5
Gunzenhausen 5
Ronco 5
Dong Ket 4
Menlo Park 4
Milan 4
Trieste 4
Villar Focchiardo 4
Asti 3
Borgomanero 3
Bulandshahr 3
Cairo 3
Cambridge 3
Carpi 3
Chengdu 3
Genoa 3
Lucca 3
Naples 3
Ningbo 3
Padova 3
Quzhou 3
Rome 3
Seattle 3
Zhengzhou 3
Assago 2
Bari 2
Biella 2
Changchun 2
Chaoyang 2
Des Moines 2
Düsseldorf 2
Espoo 2
Giaveno 2
Hayward 2
Henderson 2
Huskvarna 2
Innsbruck 2
Lerici 2
Montevideo 2
Nanchang 2
Rio de Janeiro 2
Sherbrooke 2
Simi Valley 2
Totale 4.954
Salva come PNG Salva come JPEG
Nome #
Transition metal carbonyl clusters in biology: A futile or niche research area? 103
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 98
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen 96
Different strategies to exploit Pt(IV) complexes as pro-drugs 92
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 91
Estradiol as Carrier For Selective Delivery of Cytotoxic Pt(II) Complexes to Cancer Cell Nuclei 88
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 87
195Pt NMR chemical shift: a chemometric approach 85
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 83
Experimental (RP-HPLC) and theoretical (MIFs) study of the lipophilicity of a series of Pt(IV) complexes 83
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 82
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 81
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 80
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 79
A different way for the oxidation of the Pt(II) complexes 79
Experimental and molecular modeling approaches to determine the lipophilicity of a Pt(IV) pro-drugs 78
Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling 77
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 76
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 76
Pyrazolyl-diamine Pt(II) complexes bearing DNA-intercalating moieties: Synthesis, characterization and in vitro evaluation 75
Application of microwave-assisted heating to the synthesis of Pt(II) complexes 75
A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination 74
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 74
Antiproliferative Activity of PtII Complexes with Carboxylated Phosphanes in Chelated or Ring-Opened Forms 73
Assessment of the anticancer potentiality of a new platinum nanoparticulate coniugate 71
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 71
Bidentate and tridentate pyrazolyl-containing Pt(II) complexes: synthesis, characterization and in vitro evaluation 70
Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines 70
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 69
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 69
Prediction of logP for Pt(II) and Pt(IV) complexes: Comparison of statistical and quantum-chemistry based approaches 69
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 68
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 68
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 68
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 67
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 67
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 66
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 66
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 66
Pt(IV) complexes as anticancer prodrugs 66
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 65
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 65
Solvolysis of a Series of Cisplatin-Like Complexes – Comparison between DNA-Biosensor and Conductivity Data 65
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 64
Antitumor platinum(IV) pro-drugs: synthesis, characterization, cytotoxicity and QSAR analysis 64
Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex 63
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 63
A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives 63
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 62
Cytotoxicity of some Pt(II)-diamine complexes: a QSAR evaluation of the effect of chelating arms and leaving groups 61
A view on multi-action Pt(IV) antitumor prodrugs 61
Effects of dimethylsulfoxide and ethanol on the cytotoxic activity of titanocene dichloride 60
Pt-195 NMR spectroscopy: A chemometric approach 60
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 60
Anthracene-terpyridine metal complexes as new G-quadruplex DNA binders 60
Experimental determination and modeling of the lipophilicity in platinum complexes 59
Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: A quantitative structure-activity relationship approach 58
Bioinorganic chemistry: the study of the fate of platinum-based antitumour drugs 57
Bifunctional Ethacrynic Acid – Pt Conjugates: In vitro Treatment of Malignant Pleural Mesothelioma 57
Molecular Interaction Fields vs. Quantum-Mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes 57
Pt(IV)/Re(I) Chitosan Conjugates as a Flexible Platform for the Transport of Therapeutic and/or Diagnostic Anticancer Agents 57
How to obtain Pt(IV) complexes suitable for conjugation to nanovectors from the oxidation of [PtCl(terpyridine)]+ 56
Solvolysis of Cisplatin and N-Methylated cis-[PtCl2(en)] Complexes – Comparison between DNA-Biosensor and Conductivity Data 55
Assessment of the in vivo antiproliferative activity of a novel platinum nanoparticulate pharmacophore 55
Synthesis of PtIV-Biomolecule Conjugates through Click Chemistry 55
Assessment of the in vivo antiproliferative activity of a novel particulate pharmacophore 54
A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes 54
Classical Pt(II) anticancer complexes revised in view of drug targeting and delivery 53
Cellular uptake of antitumor platinum(II)-complexes evaluated by means of ICP-MS technique 53
In Vitro And In Vivo Activity Of A New Platinum Nanoparticulate Coniugate 53
Functionalized thymidine derivatives as carriers for the γ-emitter technetium tricarbonyl moiety 53
Biological Activity of Enantiomeric Complexes [PtCl2L2] (L2 = Aromatic Bisphosphanes and Aromatic Diamines) 52
Pros and cons of bifunctional platinum(iv) antitumor prodrugs: two are (not always) better than one 52
trans,cis,cis-Bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin-Refractory Colorectal Cancer 51
Conjugation between maleimide-containing Pt(IV) prodrugs and furan or furan-containing drug delivery vectors via Diels-Alder cycloaddition 51
Freshening up Old Methods for New Students: A Colorful Laboratory Experiment to Measure the Formation Constants of Ni(II) Complexes Containing Ethane-1,2-Diamine 50
The influence of temperature on antiproliferative effects, cellular uptake and DNA platination of the clinically employed Pt(II)-drugs 49
Trend in cytotoxic activity of a series of cis-[APtCl(2)] (A = ethylenediamine methylated at different positions) complexes 49
Organometallic compounds in the discovery of new agents against kinetoplastid-caused diseases 49
Estrogenic carriers for cytotoxic Pt(II) complexes: light and shade 48
Study of methylation of carrier ligands in cis-[APtCl2] (A = substituted ethylenediamine) complexes 48
log Po/w determination for a series of Pt(II) complexes by means of reverse phase HPLC 48
Poly(methylmetacrylate) (PMMA) core-shell nanospheres act as efficient pharmacophores for the antiproliferative [PtCl3(NH3)]- complex by forming ionic couples 48
Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes 48
Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies 48
HPLC method for the determination of monomer conversion and composition during the poly(styrene-r-methylmethacrylate) polymerization 48
Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake? 48
Pt(iv) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activity 48
Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(iv) complexes to obtain antiproliferative agents against human glioblastoma cells 47
Synthesis And Characterization of Estradiol Derived Platinum Complexes 47
Synthesis and characterisation of estrogenic carriers for cytotoxic Pt(II) fragments: biological activity of the resulting complexes 47
Studies on Log Po/w of Quinoxaline di-N-Oxides: A Comparison of RP-HPLC Experimental and Predictive Approaches 47
Platinum(II) and technetium(I) complexes anchored to ethynylestradiol: a way to drug targeting and delivery 47
The RP-HPLC measurement and QSPR analysis of log Po/w values of several Pt(II) complexes 47
Elusive Intermediates in the Breakdown Reactivity Patterns of Prodrug Platinum(IV) Complexes 47
Pt(iv) antitumor prodrugs: dogmas, paradigms, and realities 47
Ethynylestradiol-Pt(II) complexes for selective drug targeting 46
Relationship Among Potency (IC50), Reduction Potential (E°’) And Partition Coefficient (log Po/w) Of New Antitumour Pt(IV) Complexes 46
Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS) 46
Ethynylestradiol Derivatives as Carrier for Selective Vehiculation of Cytotoxic Pt(II)-Malonate and Radioactive Tc Fragments Towards Cancer Cells 45
Totale 6.292
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.275
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.275
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020267 0 0 0 0 0 0 0 0 0 123 138 6
2020/2021914 132 7 135 9 106 27 141 4 150 46 140 17
2021/2022979 64 17 110 114 42 0 138 27 64 23 174 206
2022/20232.176 148 89 159 48 133 204 45 125 1.085 35 69 36
2023/2024676 48 59 57 11 103 0 130 8 9 4 146 101
2024/20251.048 16 49 88 25 70 94 158 82 312 154 0 0
Totale 8.077